Corbus Pharmaceuticals Holdings, Inc. (CRBP) Operating cash flow 2016–2025
Corbus Pharmaceuticals Holdings, Inc. (CRBP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$64.5MFY2025 · since FY2016: -$13.6M → -$64.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$64.5M | -54.3% |
| FY2024 | -$41.8M | -15.8% |
| FY2023 | -$36.1M | +3.8% |
| FY2022 | -$37.5M | +22.1% |
| FY2021 | -$48.2M | +51.7% |
| FY2020 | -$99.7M | -118.0% |
| FY2019 | -$45.7M | -52.1% |
| FY2018 | -$30.1M | -8.2% |
| FY2017 | -$27.8M | -104.8% |
| FY2016 | -$13.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice